Page last updated: 2024-08-24

duloxetine hydrochloride and trimebutine

duloxetine hydrochloride has been researched along with trimebutine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Appel, D; Congiu, L; Hermans-Borgmeyer, I; Kleene, R; Loers, G; Lutz, D; Schachner, M; Schäfer, MKE1
Dbar, SR; Degterev, DA; Diukova, GM; Indejkina, LK; Makarova, AA; Parfenov, AI; Romashkina, NV; Ruchkina, IN1

Trials

1 trial(s) available for duloxetine hydrochloride and trimebutine

ArticleYear
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
    Terapevticheskii arkhiv, 2022, Sep-05, Volume: 94, Issue:2S

    Topics: Adult; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Pain; Serotonin and Noradrenaline Reuptake Inhibitors; Trimebutine

2022

Other Studies

1 other study(ies) available for duloxetine hydrochloride and trimebutine

ArticleYear
Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:2

    Topics: Animals; Cells, Cultured; Cerebellum; Cerebral Ventricles; Corpus Callosum; Duloxetine Hydrochloride; Genetic Diseases, X-Linked; Intellectual Disability; Locomotion; Male; Mice; Mice, Inbred C57BL; Mutation; Neural Cell Adhesion Molecule L1; Neurogenesis; Neurons; Peptidomimetics; Phenotype; Spastic Paraplegia, Hereditary; Toluidines; Trimebutine

2021